Published on 15 December 2021
Description:
Patient-centricity – the importance of face-to-face support; why AMR requires new, innovative and durable tools to treat microbial infections
Categories:
Pharmaceutical Market EuropePreview:
26 articles from this collection:
PME December 2021
2 - Subscribe
3 - Comment
4 - T40
5 - Contents TO DO
6-7 - News
6-7 - PME - Pharma Market Europe Pharmaceutical News
8-9 - News
10-11 - Coronavirus news
12 - The great data event
12 - Pharma Market Europe Darwin’s medicine
13 - A TOUGH PILL TO SWALLOW
The technology responses to this pandemic have fallen far short of expectations
14 - 'Tis the season to be kind
15 - Is it time to rethink expert engagement?
16-17 - Combating antimicrobial resistance
18-19 - rapid drug discovery under the microscope
18-19 - Empowering patients empowers results
20-21 - The new normal: gene therapy
22-27 - PMEA RESULTS
30-31 - Patient-centricity: why face-to-face support needs to go hand-in-hand with remote care
32 - Why a culture of innovation is essential – and how to build it
33 - Reframing clinical trial recruitment
34-35 - Patient-reported outcomes – all PROs and no cons?
36-37 - Mastering relationships
38-40 - Appointments
41 - Healthcare Comms News
42 - Q&A with simon wilson
43 - Recruitment
43 - Pharma Market Europe (PME) Recruitment
44 - 90ten
Pharmaceutical Market Europe (PME)
Pharmaceutical industry news, articles, jobs, reports, advice and services